Kobayashi K, Nagai H, Matsui T, Matsuda T, et al. Importance of Atezolizumab Plus Bevacizumab Combination Treatment as First-line Therapy for Immunological Changes in Patients With Unresectable Hepatocellular Carcinoma. Anticancer Res 2023;43:4601-4609.
PMID: 37772595